Biogen (BIIB) Misses Q4 EPS by 23c, Offers Guidance
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $220.83 -1.64%
EPS Growth %: -57.8%
Financial Fact:
Basic earnings per share attributable to Biogen Idec Inc.: 218.9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -57.8%
Financial Fact:
Basic earnings per share attributable to Biogen Idec Inc.: 218.9M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q4 EPS of $2.95, $0.23 worse than the analyst estimate of $3.18. Revenue for the quarter came in at $2.4 billion versus the consensus estimate of $2.47 billion.
GUIDANCE:
Biogen sees FY2024 EPS of $15.00-$16.00, versus the consensus of $15.64.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) PT Raised to $245 at Piper Sandler
- Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance
- UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
